Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Body Weight D001835 333 associated lipids
Arteriosclerosis D001161 86 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
pmid:
Edelstyn GA and MacRae KD "Early" and "late" breast cancer: a unified concept for treatment. 1976 Clin Radiol pmid:1000891
Schley G et al. [Oral contraceptives in prophylaxis of acute exacerbations of intermittent porphyria (author's transl)]. 1976 Dtsch. Med. Wochenschr. pmid:1001215
Jori A and Dolfini E Modifications of striatal dopamine levels by steroid contraceptive drugs in mice and rats. 1976 Neuroendocrinology pmid:1004687
Surrey ES Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? Add-Back Consensus Working Group. 1999 Fertil. Steril. pmid:10065775
Graff-Iversen S et al. Serum lipids in postmenopausal or perimenopausal women using estrogen alone, estrogen with levonorgestrel, or estrogen with norethisterone, compared with nonusers: results from a cross-sectional study in two Norwegian counties 1985-1988. 1998 J Clin Epidemiol pmid:10086825
Kimmerle R et al. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women. 1999 Menopause pmid:10100178
Rundle FW Cervical teratoma. 1976 J Otolaryngol pmid:1011335
Beckman G et al. Naphthylamidase isoenzymes in serum during treatment with oral contraceptives. 1976 Int J Gynaecol Obstet pmid:10197
Loi CM et al. Effect of troglitazone on the pharmacokinetics of an oral contraceptive agent. 1999 J Clin Pharmacol pmid:10197300
Franklin RD and Kutteh WH Characterization of immunoglobulins and cytokines in human cervical mucus: influence of exogenous and endogenous hormones. 1999 J. Reprod. Immunol. pmid:10221733
Barditch-Crovo P et al. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive. 1999 Clin. Pharmacol. Ther. pmid:10223781
Fender GR et al. Randomised controlled trial of educational package on management of menorrhagia in primary care: the Anglia menorrhagia education study. 1999 BMJ pmid:10231255
Soutoul JH et al. [Oral contraception by means of progestagen-only micropills taken continuously in the light of four recent trials (author's transl)]. 1976 Rev Fr Gynecol Obstet pmid:1023328
Hampton AL et al. Progesterone analogues similarly modulate endometrial matrix metalloproteinase-1 and matrix metalloproteinase-3 and their inhibitor in a model for long-term contraceptive effects. 1999 Mol. Hum. Reprod. pmid:10321809
Elstein M et al. The effect of daily norethisterone (0.35 mg) on cervical mucus and on urinary LH, pregnanediol and oestrogen levels. 1976 Br J Obstet Gynaecol pmid:1032819
Pérez-Medina T et al. Atypical endometrial hyperplasia treatment with progestogens and gonadotropin-releasing hormone analogues: long-term follow-up. 1999 Gynecol. Oncol. pmid:10329050
Charkoudian N and Johnson JM Altered reflex control of cutaneous circulation by female sex steroids is independent of prostaglandins. 1999 Am. J. Physiol. pmid:10330248
Gruber DM et al. Endometrial cancer after combined hormone replacement therapy. 1999 Maturitas pmid:10340283
Scheffler MR et al. Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics. 1999 Clin. Pharmacol. Ther. pmid:10340913